Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roland Wolf

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
Plos One|October 3, 2013
Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivityYusuf Y Deeni, Sally H Ibbotson, Julie A Woods, et al.
Critical Reviews in Toxicology|January 19, 2026
Letter to the editor regarding the review article: Yamada T, Cohen SM, Lake BG. The modes of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR) and the peroxisome proliferator-activated receptor alpha (PPARα) are not relevant to human cancer risk: an updated critical evaluation. Crit Rev Toxicol. 2025;55(5):549-586. doi: 10.1080/10408444.2025.2513332C Roland Wolf, Colin J Henderson, Michael Schwarz, et al.
Assay and Drug Development Technologies|May 21, 2010
Peroxiredoxin gene expression signatures in liver reflect toxic insultRachel Young, John D Hayes, Ken Brown, et al.
Transgenic Research|January 15, 2010
Spatial monitoring of toxicity in HMOX-LacZ transgenic miceRachel Young, C Roland Wolf, Ken Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2009
Markedly enhanced colon tumorigenesis in Apc(Min) mice lacking glutathione S-transferase PiKenneth J Ritchie, Shaun Walsh, Owen J Sansom, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 28, 2014
Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXRAlbert Braeuning, Alina Gavrilov, Susan Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2007
Conditional deletion of cytochrome P450 oxidoreductase in the liver and gastrointestinal tract: a new model for studying the functions of the P450 systemRobert D Finn, Aileen W McLaren, Dianne Carrie, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 9, 2017
Novel Pathways of Ponatinib Disposition Catalyzed By CYP1A1 Involving Generation of Potentially Toxic MetabolitesDe Lin, Rumen Kostov, Jeffrey T-J Huang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2002
CYP3A4 active site volume modification by mutagenesis of leucine 211Stephen M Fowler, John M Taylor, Thomas Friedberg, et al.
Biochemistry|April 3, 2002
Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme bindingAldo Gutierrez, Mark Paine, C Roland Wolf, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
Plos One|October 3, 2013
Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivityYusuf Y Deeni, Sally H Ibbotson, Julie A Woods, et al.
Critical Reviews in Toxicology|January 19, 2026
Letter to the editor regarding the review article: Yamada T, Cohen SM, Lake BG. The modes of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR) and the peroxisome proliferator-activated receptor alpha (PPARα) are not relevant to human cancer risk: an updated critical evaluation. Crit Rev Toxicol. 2025;55(5):549-586. doi: 10.1080/10408444.2025.2513332C Roland Wolf, Colin J Henderson, Michael Schwarz, et al.
Assay and Drug Development Technologies|May 21, 2010
Peroxiredoxin gene expression signatures in liver reflect toxic insultRachel Young, John D Hayes, Ken Brown, et al.
Transgenic Research|January 15, 2010
Spatial monitoring of toxicity in HMOX-LacZ transgenic miceRachel Young, C Roland Wolf, Ken Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2009
Markedly enhanced colon tumorigenesis in Apc(Min) mice lacking glutathione S-transferase PiKenneth J Ritchie, Shaun Walsh, Owen J Sansom, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 28, 2014
Phenobarbital-mediated tumor promotion in transgenic mice with humanized CAR and PXRAlbert Braeuning, Alina Gavrilov, Susan Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2007
Conditional deletion of cytochrome P450 oxidoreductase in the liver and gastrointestinal tract: a new model for studying the functions of the P450 systemRobert D Finn, Aileen W McLaren, Dianne Carrie, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 9, 2017
Novel Pathways of Ponatinib Disposition Catalyzed By CYP1A1 Involving Generation of Potentially Toxic MetabolitesDe Lin, Rumen Kostov, Jeffrey T-J Huang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2002
CYP3A4 active site volume modification by mutagenesis of leucine 211Stephen M Fowler, John M Taylor, Thomas Friedberg, et al.
Biochemistry|April 3, 2002
Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme bindingAldo Gutierrez, Mark Paine, C Roland Wolf, et al.
Pageof 16